Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 376 AL 390

Tauopathies: Emerging discoveries on tau protein, with a special focus on Alzheimer's disease

Hattiholi A, Hegde H, Shetty SK.

Neuropeptides. 2025 Aug;112:102536. doi: 10.1016/j.npep.2025.102536. Epub 2025 Jul 2.

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan P, Wadhwa K, Singh G.

Pathol Res Pract. 2025 Aug;272:156109. doi: 10.1016/j.prp.2025.156109. Epub 2025 Jul 5.

CTAD taskforce: genetic therapies in Alzheimer's disease

Jakabek D, Isaacs AM, De Strooper B, Tuszynski M, Lane R, Uspenskaya O, McDade E, Rafii MS, Mummery CJ.

J Prev Alzheimers Dis. 2025 Sep;12(8):100269. doi: 10.1016/j.tjpad.2025.100269. Epub 2025 Jul 9.

Decoding tau acetylation in Alzheimer's disease and tauopathies: from site-specific mechanisms to therapeutic horizons

Oh YR, Shin MK.

BMB Rep. 2025 Aug;58(8):325-339. doi: 10.5483/BMBRep.2025-0077.

Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies

Franceschi AM, Keir G, Benzinger TLS, Cogswell PM, Ali FZ, Petrella JR, Prescott JW, Whitlow CT, Zaharchuk G, Allen JW; American Society of Functional Neuroradiology (ASFNR).

AJNR Am J Neuroradiol. 2025 Aug 1;46(8):1521-1527. doi: 10.3174/ajnr.A8738.

Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier

Bashir DJ, Bhat KA, Bashir M.

Brain Res. 2025 Sep 15;1863:149828. doi: 10.1016/j.brainres.2025.149828. Epub 2025 Jul 9.

Recent Advances in Antibody Therapy for Alzheimer's Disease: Focus on Bispecific Antibodies

Yang HM.

Int J Mol Sci. 2025 Jun 28;26(13):6271. doi: 10.3390/ijms26136271.

Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy

Almohmadi NH, Al-Kuraishy HM, Albuhadily AK, Al-Gareeb AI, Abdelaziz AM, Alexiou A, Papadakis M, El-Saber Batiha G.

J Pharmacol Exp Ther. 2025 Aug;392(8):103639. doi: 10.1016/j.jpet.2025.103639. Epub 2025 Jun 20.

Deciphering Molecular and Signaling Pathways of Extracellular Vesicles-Based Therapeutics for Alzheimer's Disease

Dhapola R, Kumari S, Sharma P, Paidlewar M, Medhi B, Vellingiri B, HariKrishnaReddy D.

Mol Neurobiol. 2025 Dec;62(12):15430-15449. doi: 10.1007/s12035-025-05216-6. Epub 2025 Jul 18.

Eriocitrin and its derivatives against Alzheimer's disease: Cumulative accounts of in vitro and in vivo studies

Kritika, Sanjay, Lee HJ.

Biomed Pharmacother. 2025 Sep;190:118362. doi: 10.1016/j.biopha.2025.118362. Epub 2025 Jul 21.

A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease

Alshehri GH, Al-Kuraishy HM, Al-Gareeb AI, Fawzy MN, Waheed HJ, Papadakis M, Alexiou A, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 15;1003:177979. doi: 10.1016/j.ejphar.2025.177979. Epub 2025 Jul 22.

Is dolichol pathway dysfunction a significant factor in Alzheimer's disease?

Schloss JV.

Inflammopharmacology. 2025 Aug;33(8):4651-4658. doi: 10.1007/s10787-025-01868-x. Epub 2025 Jul 25.

Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management

Cerasuolo M, Auriemma MC, Di Meo I, Lenti C, Papa M, Paolisso G, Rizzo MR.

Int J Mol Sci. 2025 Jul 12;26(14):6693. doi: 10.3390/ijms26146693.

The role of peripheral innate immune cells in Alzheimer's disease progression

Cao Y, Tang K, Ma P, Zhang R, Yang Y, Li T, Zhang Y, Peng X.

Front Immunol. 2025 Jul 16;16:1616939. doi: 10.3389/fimmu.2025.1616939. eCollection 2025.

Exploring the Interconnections of Genetic, Lifestyle, and Epigenetic Influences on Brain Aging: A Comprehensive Review

Mehrabadi S, Barati S.

Curr Alzheimer Res. 2025;22(7):488-501. doi: 10.2174/0115672050393583250718145103.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias